Safety of bevacizumab plus chemotherapy as first-line treatment of patients with metastatic colorectal cancer: Updated results from a large observational registry in the US (BRiTE).

被引：0
|
作者：
Hedrick, E.
Kozloff, M.
Hainsworth, J.
Badarinath, S.
Cohn, A.
Flynn, P.
Dong, W.
Suzuki, S.
Sugrue, M.
Grothey, A.
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Florida Oncol Associates, Jacksonville, FL USA
[5] Rocky Mt Canc Ctr, Denver, CO USA
[6] Abbott NW Hosp, Minneapolis, MN 55407 USA
[7] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3536
引用
收藏
页码：155S / 155S
页数：1
相关论文
共 50 条
  • [21] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    M. Ozcelik
    H. Odabas
    O. Ercelep
    S. Yuksel
    A. G. Mert
    D. Aydin
    H. Surmeli
    D. Isik
    S. Isik
    A. Oyman
    B. B. Oven Ustaalioglu
    M. Aliustaoglu
    M. Gumus
    Clinical and Translational Oncology, 2016, 18 : 617 - 624
  • [22] ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK
    Khakoo, Shelize
    Chau, Ian
    Pedley, Ian
    Ellis, Richard
    Steward, Will
    Harrison, Mark
    Baijal, Shobhit
    Tahir, Saad
    Ross, Paul
    Raouf, Sherif
    Ograbek, Agnes
    Cunningham, David
    CLINICAL COLORECTAL CANCER, 2019, 18 (04) : 280 - +
  • [23] FOLFOXIRI PLUS BEVACIZUMAB AS FIRST-LINE TREATMENT OF BRAF MUTANT METASTATIC COLORECTAL CANCER PATIENTS
    Salvatore, Lisa
    Loupakis, Fotios
    Cremolini, Chiara
    Schirripa, Marta
    Masi, Gianluca
    Antoniotti, Carlotta
    Fornaro, Lorenzo
    Sensi, Elisa
    Lupi, Cristiana
    Bergamo, Francesca
    Lonardi, Sara
    Zagonel, Vittorina
    Fontanini, Gabriella
    Falcone, Alfredo
    ANNALS OF ONCOLOGY, 2012, 23 : 93 - 93
  • [24] Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment
    Huang, Ching-Wen
    Yeh, Yung-Sung
    Ma, Cheng-Jen
    Tsai, Hsiang-Lin
    Chen, Chao-Wen
    Huang, Ming-Yii
    Lu, Chien-Yu
    Wu, Jeng-Yih
    Wang, Jaw Yuan
    CHEMOTHERAPY, 2017, 62 (01) : 80 - 84
  • [25] Efficacy and safety of surgery with curative intent in patients treated with first-line Bevacizumab plus chemotherapy for metastatic colorectal cancer: First beat
    Kretzschmar, A.
    Cunningham, D.
    Berry, S.
    Rivera, F.
    Di Bartolomeo, M.
    Mazier, M.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2008, 19 : I25 - I25
  • [26] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
    Tsutsumi, Soichi
    Fujii, Takaaki
    Yamaguchi, Satoru
    Suto, Toshinaga
    Yajima, Reina
    Morita, Hiroki
    Kato, Toshihide
    Asao, Takayuki
    Kuwano, Hiroyuki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637
  • [27] Bevacizumab plus XELOX as first-line therapy for patients with metastatic colorectal cancer
    Gaspar, E.
    Juarez Marroqui, A.
    Vicent, J.
    Llorca, C.
    Orts, D.
    Galan, A.
    Barrajon, E.
    Cervera Grau, J.
    Giner, V.
    Macia, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry
    Kocakova, Ilona
    Melichar, Bohuslav
    Kocak, Ivo
    Bortlicek, Zbynek
    Buechler, Tomas
    Dusek, Ladislav
    Petruzelka, Lubos
    Kohoutek, Milan
    Prausova, Jana
    Finek, Jindrich
    Mohelnikova-Duchonova, Beatrice
    Vyzula, Rostislav
    ANTICANCER RESEARCH, 2015, 35 (06) : 3455 - 3461
  • [29] Bevacizumab in the first-line treatment of elderly patients with metastatic colorectal cancer: Mature results from a large community-based observational study.
    Hofheinz, Ralf
    Grothe, Wilfried
    Tummes, Dirk
    Kindler, Manfred
    Petersen, Volker
    Boszeit-Luft, Stefanie
    Seraphin, Joerg
    Hinke, Axel
    Arnold, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [30] Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients with metastatic colorectal cancer (MCRC): Results from the BRiTE observational cohort study
    Kozloff, M.
    Sugrue, M.
    Chiruvolu, P.
    Purdie, D.
    Berlin, J.
    Flynn, P.
    Kabbinavar, F.
    Sargent, D.
    Dong, W.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 26 - 26
12345